Oxford Cannabinoid Technologies Holdings Plc (GB:OCTP) has released an update.
Oxford Cannabinoid Technologies Holdings plc, a biopharmaceutical company specializing in cannabinoid medicines, has announced plans to cancel its listing on the London Stock Exchange’s Main Market due to unfavorable market conditions and a strategic review aimed at attracting new investment. The company remains confident in its drug development pipeline and is debt-free with no immediate cash flow concerns. The move is intended to open the company to a broader range of investment opportunities and is expected to take effect from 6 June 2024.
For further insights into GB:OCTP stock, check out TipRanks’ Stock Analysis page.